Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 13 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.85 Insider Own42.69% Shs Outstand10.62M Perf Week3.45%
Market Cap73.32M Forward P/E- EPS next Y-0.74 Insider Trans0.00% Shs Float7.00M Perf Month-0.50%
Income-64.82M PEG- EPS next Q-0.96 Inst Own11.34% Short Float0.64% Perf Quarter27.66%
Sales33.69M P/S2.18 EPS this Y-42.18% Inst Trans-15.43% Short Ratio0.41 Perf Half Y46.34%
Book/sh16.91 P/B0.35 EPS next Y79.39% ROA-19.70% Short Interest0.04M Perf Year-54.65%
Cash/sh5.95 P/C1.01 EPS next 5Y- ROE-25.15% 52W Range2.85 - 14.55 Perf YTD1.52%
Dividend Est.- P/FCF- EPS past 5Y- ROI-31.28% 52W High-58.76% Beta-0.14
Dividend TTM- Quick Ratio2.08 Sales past 5Y-15.03% Gross Margin42.48% 52W Low110.53% ATR (14)0.36
Dividend Ex-DateFeb 17, 2016 Current Ratio2.16 EPS Y/Y TTM87.07% Oper. Margin-159.69% RSI (14)56.82 Volatility4.02% 4.22%
Employees324 Debt/Eq0.01 Sales Y/Y TTM-81.66% Profit Margin-192.41% Recom1.00 Target Price9.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-1160.86% Payout- Rel Volume0.69 Prev Close6.00
Sales Surprise-27.62% EPS Surprise89.34% Sales Q/Q-89.62% EarningsApr 01 BMO Avg Volume109.70K Price6.00
SMA201.22% SMA5018.93% SMA20011.62% Trades Volume76,662 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jan-18-23Initiated Cantor Fitzgerald Overweight $7
Apr-01-24 01:53PM
Feb-09-24 09:25AM
Nov-20-23 06:00AM
Nov-01-23 06:00AM
07:10AM Loading…
Sep-15-23 07:10AM
Aug-29-23 12:46AM
Jun-30-23 08:00AM
Jun-26-23 09:30AM
Jun-25-23 08:45PM
Jun-05-23 07:20AM
Mar-14-23 08:56AM
Mar-02-23 07:00AM
Feb-02-23 04:01PM
Jan-19-23 05:00AM
10:00AM Loading…
Jan-17-23 10:00AM
Jan-10-23 08:05AM
Dec-16-22 06:27AM
Nov-30-22 09:15AM
Nov-10-22 08:00AM
Sep-09-22 11:17AM
Aug-12-22 09:34AM
Aug-08-22 04:45AM
Jul-16-22 08:03AM
Jun-08-22 12:56PM
Jun-06-22 09:55AM
May-23-22 12:00PM
May-19-22 12:15PM
May-18-22 06:30PM
11:00AM Loading…
May-17-22 11:00AM
Prenetics Global Ltd. is a genomics-driven health sciences company, which is revolutionizing prevention, early detection, and treatment of diseases. Its prevention arm, CircleDNA, uses whole exome sequencing to offer the comprehensive consumer DNA test, Insighta. Its $200 million joint venture with scientist Prof. Dennis Lo, underscores its unwavering commitment to save lives through pioneering multi-cancer early detection technologies. The company's ACT Genomics unit is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. The firm's units synergistically enhances its global impact on health and life through science. Prenetics Global was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.